Transition Therapeutics (TTHI) Misses Q3 EPS by 27c
Tweet
Share
E-mailGet Alerts TTHI Hot Sheet
Join SI Premium – FREE
Transition Therapeutics (NASDAQ: TTHI) reported Q3 EPS of ($0.45), $0.27 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Transition Therapeutics (TTHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- On Holding AG (ONON) PT Lowered to $73 at UBS on Short-Term Industry Dynamics
- NeOnc Phase 2a brain cancer trial shows 48.9% survival vs. 20% benchmark
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
